167 related articles for article (PubMed ID: 23392318)
21. Formation and Stoichiometry of CRISPR-Cascade Complexes with Varying Spacer Lengths Revealed by Native Mass Spectrometry.
Wittig S; Songailiene I; Schmidt C
J Am Soc Mass Spectrom; 2020 Mar; 31(3):538-546. PubMed ID: 32008319
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli.
Zhao H; Sheng G; Wang J; Wang M; Bunkoczi G; Gong W; Wei Z; Wang Y
Nature; 2014 Nov; 515(7525):147-50. PubMed ID: 25118175
[TBL] [Abstract][Full Text] [Related]
23. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
[TBL] [Abstract][Full Text] [Related]
24. Self versus non-self discrimination during CRISPR RNA-directed immunity.
Marraffini LA; Sontheimer EJ
Nature; 2010 Jan; 463(7280):568-71. PubMed ID: 20072129
[TBL] [Abstract][Full Text] [Related]
25. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
27. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
Charpentier E; Richter H; van der Oost J; White MF
FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
[TBL] [Abstract][Full Text] [Related]
28. Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis.
Wakefield N; Rajan R; Sontheimer EJ
FEBS Lett; 2015 Oct; 589(20 Pt B):3197-204. PubMed ID: 26364721
[TBL] [Abstract][Full Text] [Related]
29. CRISPR transcript processing: a mechanism for generating a large number of small interfering RNAs.
Djordjevic M; Djordjevic M; Severinov K
Biol Direct; 2012 Jul; 7():24. PubMed ID: 22849651
[TBL] [Abstract][Full Text] [Related]
30. RcsB-BglJ-mediated activation of Cascade operon does not induce the maturation of CRISPR RNAs in E. coli K12.
Arslan Z; Stratmann T; Wurm R; Wagner R; Schnetz K; Pul Ü
RNA Biol; 2013 May; 10(5):708-15. PubMed ID: 23392250
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cyclic oligoadenylate synthesis by the
Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
[TBL] [Abstract][Full Text] [Related]
32. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
33. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs.
Hatoum-Aslan A; Samai P; Maniv I; Jiang W; Marraffini LA
J Biol Chem; 2013 Sep; 288(39):27888-97. PubMed ID: 23935102
[TBL] [Abstract][Full Text] [Related]
34. Structure and RNA-binding properties of the type III-A CRISPR-associated protein Csm3.
Hrle A; Su AA; Ebert J; Benda C; Randau L; Conti E
RNA Biol; 2013 Nov; 10(11):1670-8. PubMed ID: 24157656
[TBL] [Abstract][Full Text] [Related]
35. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.
Burmistrz M; Rodriguez Martinez JI; Krochmal D; Staniec D; Pyrc K
J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28893837
[TBL] [Abstract][Full Text] [Related]
36. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
[TBL] [Abstract][Full Text] [Related]
38. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
39. Interference activity of a minimal Type I CRISPR-Cas system from Shewanella putrefaciens.
Dwarakanath S; Brenzinger S; Gleditzsch D; Plagens A; Klingl A; Thormann K; Randau L
Nucleic Acids Res; 2015 Oct; 43(18):8913-23. PubMed ID: 26350210
[TBL] [Abstract][Full Text] [Related]
40. Structure of an RNA silencing complex of the CRISPR-Cas immune system.
Spilman M; Cocozaki A; Hale C; Shao Y; Ramia N; Terns R; Terns M; Li H; Stagg S
Mol Cell; 2013 Oct; 52(1):146-52. PubMed ID: 24119404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
